Fig. 4From: The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective studyLine Chart of CRP changes at 0, 4, 8 and 12 weeks. CRP: C-reactive proteinBack to article page